Program
KL0011034
A development code. Also written as “KL0011034 injection”.
Its studies are mostly in Chronic Pain, led by Sichuan Kelun Pharmaceutical.
Furthest: phase 1, since Feb 24, 20264 company-led studies, 3 open or runningNext primary completion: Nov 24, 2026 (phase 1)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sichuan Kelun Pharmaceutical | 43 open or running | phase 1since Feb 24, 2026 | Feb 24, 2026 | Nov 24, 2026phase 1 · NCT07913048 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 24, 2026First study: phase 1 study in Healthy VolunteersFirst studyNCT07474545 · 76 planned · China
- Jul 5, 2026Phase 1 study in Chronic PainNCT07710560 · 27 enrolled · China
- Sep 11, 2026Phase 1 study in Healthy VolunteersNCT07828470 · 30 planned · China
- Oct 28, 2026Phase 1 study in Healthy ParticipantsNCT07913048 · 20 planned · China
Ahead
- Nov 13, 2026Primary completion: phase 1 study in Healthy VolunteersNCT07828470
- Nov 24, 2026Primary completion: phase 1 study in Healthy ParticipantsNCT07913048
- Dec 31, 2027Primary completion: phase 1 study in Healthy VolunteersNCT07474545
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07913048Healthy Participants · China | 1 | Not yet recruiting | Nov 24, 2026 | 20 |
| NCT07828470Healthy Volunteers · China | 1 | Not yet recruiting | Nov 13, 2026 | 30 |
| NCT07710560Chronic Pain · China | 1 | Completed | Aug 12, 2026 | 27 |
| NCT07474545Healthy Volunteers · China | 1 | Recruiting | Dec 31, 2027 | 76 |
How it is read
Names in the registry
- “KL0011034 injection”, 4 entries
Codes read as this program: KL0011034.
Conditions, from the studies’ own filings
- Chronic Pain, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.